Loading clinical trials...
Loading clinical trials...
The primary purpose of the protocol is to evaluate the long-term safety of pregabalin in patients with partial seizures.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT05015868 · Epilepsies, Partial, Epilepsy Intractable
NCT03054961 · Epilepsies, Partial
NCT06374966 · Epilepsies, Partial
NCT03446664 · Epilepsies, Partial, Epilepsy, Tonic-Clonic
NCT03200769 · Sleep Apnea Syndromes, Epilepsies, Partial
Pfizer Investigational Site
Innsbruck
Pfizer Investigational Site
Mauer bei Amstetten
Pfizer Investigational Site
Sankt Pölten
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions